Assignee
ELUCIDA ONCOLOGY INC
US·2 granted patents·1 pending application·2 citations·filing 2022–2023
Top patents by PatentIndex Score
3 records- 0188US11744897B2Folate receptor targeted nanoparticle drug conjugates and uses thereofELUCIDA ONCOLOGY INC·Filed 2022·Granted Sep 5, 2023·2 cites·30 claims
- 0274US11957760B2Folate receptor targeted nanoparticle drug conjugates and uses thereofELUCIDA ONCOLOGY INC·Filed 2023·Granted Apr 16, 2024·0 cites·30 claims
- 0370US2023241243A1Carrier particle-drug conjugates, self-immolative linkers, and uses thereofELUCIDA ONCOLOGY INC·Filed 2023·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when ELUCIDA ONCOLOGY INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →